Genetic Technologies Limited
GNTLF
$1.00
$0.998990,809.09%
| Weiss Ratings | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -620.95 | |||
| Price History | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 90,809.09% | |||
| 90-Day Total Return | 9,900.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 1,328.57% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | 400.00% | |||
| 5-Year Total Return | 900.00% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 90,809.09% | |||
| Price | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 09, 2024 | |||
| 52-Week High Price (Date) | Dec 20, 2024 | |||
| Valuation | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.57M | |||
| Enterprise Value | 3.47M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -21.77% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 23.53 | |||
| Price/Book (Q) | 108.70 | |||
| Enterprise Value/Revenue (TTM) | 0.54 | |||
| Price | $1.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.52 | |||
| Enterprise Value/EBIT | -0.49 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 149.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 61 3 8412 7000 | |||
| Address | 321 Chapel Street Prahran, VIC 3181 | |||
| Website | genetype.com | |||
| Country | Australia | |||
| Year Founded | 1987 | |||
| Profitability | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -109.53% | |||
| Profit Margin | -124.20% | |||
| Management Effectiveness | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -61.97% | |||
| Return on Equity | -- | |||
| Income Statement | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.03M | |||
| Total Revenue (TTM) | 6.34M | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | 3.88M | |||
| EBITDA (TTM) | -6.60M | |||
| EBIT (TTM) | -6.95M | |||
| Net Income (TTM) | -7.88M | |||
| Net Income Avl. to Common (TTM) | -7.88M | |||
| Total Revenue Growth (Q YOY) | -11.83% | |||
| Earnings Growth (Q YOY) | 12.21% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | 34.74% | |||
| Balance Sheet | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 693.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 2.47M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.22M | |||
| Current Ratio (Q) | 0.881 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 4.13M | |||
| Total Current Liabilities (Q) | 2.80M | |||
| Total Debt (Q) | 583.90K | |||
| Total Liabilities (Q) | 2.91M | |||
| Total Common Equity (Q) | 1.22M | |||
| Cash Flow | GNTLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 75.20K | |||
| Cash from Financing (TTM) | 1.86M | |||
| Net Change in Cash (TTM) | -4.48M | |||
| Levered Free Cash Flow (TTM) | -3.75M | |||
| Cash from Operations (TTM) | -6.35M | |||
